Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
J-shaped Association Between Fasting Blood Glucose Levels and COVID-19 Severity in Patients without Diabetes
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
covidontheweb.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
title
J-shaped Association Between Fasting Blood Glucose Levels and COVID-19 Severity in Patients without Diabetes
Creator
Wang, Zhen
Wang, Z
Chen, Dong
Qu, Shen
Wang, X
Zhu, Bing
Hu, Chenchan
Sun, H
Author,
Chen, D
Jin, Shengwei
Bu, L
Bu, Le
Hu, C
Qu, S
Sun, Hang
Wang, Xingchun
Wu, L
Wu, Lianpeng
source
Elsevier; Medline; PMC
abstract
Abstract Aims coronavirus disease 2019 (COVID-19) has become a recognized worldwide pandemic. Researchers now know that mortality from COVID-19 can be reduced through early prevention measures. This retrospective, multi-centered study of 293 COVID-19 patients without diabetes explores the association between fasting blood glucose (FBG) levels and the risk of COVID-19 disease progression, with the goal of providing clinical evidence for glycemic targets in patients. Methods the multivariate stepwise binary logistic regression analysis was used to test the dose-response effects of FBG levels on the risk of severe and critical condition in COVID-19 patients. Results FBG levels were plotted in quintiles with set at < 4.74, 4.74-5.21, 5.21-5.78, 5.78-7.05, and ≧7.05 mmol/L. The constituent ratio of severe or critical cases in each FBG quintile was 20.7%, 1.7%, 13.8%, 27.1%, and 67.2%, respectively (P < 0.0001). When the second quintile was used as the reference, the adjusted odds ratios (AORs) (95%CI) for the risk of severe/critical condition in COVID-19 was 25.33(2.77, 231.64), 1.00 (Reference), 3.13(0.33, 29.67), 10.59(1.23, 91.24), 38.93(4.36, 347.48) per FBG quintile respectively (P < 0.001). Conclusions we provide evidence of J-shaped associations between FBG and risk of severe and critical condition in non-diabetes patients with COVID-19, with nadir at 4.74-5.78 mmol/L.
has issue date
2020-08-25
(
xsd:dateTime
)
bibo:doi
10.1016/j.diabres.2020.108381
bibo:pmid
32853687
has license
els-covid
sha1sum (hex)
d966ee1333a9d2b7af2a15cb6a52145f80ca0a15
schema:url
https://doi.org/10.1016/j.diabres.2020.108381
resource representing a document's title
J-shaped Association Between Fasting Blood Glucose Levels and COVID-19 Severity in Patients without Diabetes
has PubMed Central identifier
PMC7445136
has PubMed identifier
32853687
schema:publication
Diabetes Res Clin Pract
resource representing a document's body
covid:d966ee1333a9d2b7af2a15cb6a52145f80ca0a15#body_text
is
schema:about
of
named entity 'blood glucose'
named entity 'coronavirus disease 2019'
named entity 'pandemic'
named entity 'Journal'
named entity 'MULTI'
named entity 'MORTALITY'
named entity 'GOAL'
named entity 'CLINICAL'
named entity 'ASSOCIATION'
named entity 'CENTERED'
named entity 'EVIDENCE FOR'
named entity 'clinical evidence'
named entity 'fasting'
named entity 'retrospective'
named entity 'Patients'
named entity 'Patients'
named entity 'Blood'
named entity 'COVID-19'
named entity 'Diabetes'
named entity 'Glycemic'
named entity 'COVID-19.'
named entity 'simple correlation'
named entity 'statistically significant'
named entity 'mmol/L'
named entity 'fever'
named entity 'glucose'
named entity 'COVID-19'
named entity 'antiinflammatory'
named entity 'diabetes'
named entity 'hepatic failure'
named entity 'hypoglycemia'
named entity 'inflammatory cytokine'
named entity 'diabetes'
named entity 'COVID'
named entity 'risk factor'
named entity 'elevated glucose levels'
named entity 'MERS-CoV'
named entity 'ATP'
named entity 'FBG'
named entity 'COVID'
named entity 'mmol/L'
named entity 'diabetes'
named entity 'anti-inflammatory'
named entity 'sample size'
named entity 'risk factor'
named entity 'pneumonia'
named entity 'COVID'
named entity 'anti-oxidant'
named entity 'AORs'
named entity 'viral infection'
named entity 'ADA'
named entity 'Student's t-test'
named entity 'COVID'
named entity 'COVID'
named entity 'infection'
named entity 'blood glucose levels'
named entity 'statistical analysis'
named entity 'FBG'
named entity 'Wenzhou'
named entity 'National Institute for Viral Disease Control and Prevention'
named entity 'C.H.'
named entity 'mmol/L'
named entity 'diabetes'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 6
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software